Catalyst Wire Dossier Catalyst Wire Dossier

Alvespimycin

alvespimycin · Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alvespimycin, covering 2015-11-04 to 2015-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer [Phase 2]

See pricing